Space drug companies seek zero gravity as ISS retirement nears
As the aging International Space Station approaches retirement, biotech firms and drugmakers are signing deals with commercial space stations to continue drug research in zero gravity. Nancy Lapid reports.

This headline comes from the wire. Read the full story at the original publisher:
Continue reading at Reuters →



